Skip to main content

Table 1 Demographic data of Shigella -infected patients on the day of enrollment a

From: Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial

Features Study patients (N = 76) p valueb
Intervention group Placebo group
n = 39 n = 37
Age, yrs 34.72 ± 13.80 34.97 ± 11.20 0.93
Sex, Male: Female 23:16 19:18 0.66
Body weight, kg 46.04 ± 6.08 45.03 ± 6.96 0.5
Duration of diarrhea, days 3.41 ± 1.46 3.21 ± 0.71 0.97
Frequency of defecation, times/d 4.41 ± 4 5.06 ± 4 0.32
Stool output, g 124.71 ±148.35 83.42 ± 77.69 0.21
Fever, n (%) 18 (46.1%) 16 (43.2%) 0.82
Tenesmus, n (%) 25 (64.1%) 26 (70.3%) 0.63
Abdominal cramping, n (%) 32 (82%) 31 (83.8%) 1.0
Blood in stool, n (%) 17 (43.6%) 17 (45.9%) 1.0
  1. aData are given as mean ± standard deviation, proportion of patients or number of patients (% of total patients in each group).
  2. bStudent-t test or Chi-square test was used to compare between the groups for quantitative or categorical data, respectively. Significance: p≤ 0.05.